AstraZeneca

Business By Rebecca Robbins

Get ready for more drug ads: Facebook is making a bid for pharma dollars

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Americans say lowering drug costs is a top priority

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

AstraZeneca to pay $5.5 million for bribing doctors in China and Russia

Pharmalot By Ed Silverman

AstraZeneca loses court battle to prevent generic versions of Crestor

Pharmalot By Ed Silverman

To split or not to split? One Wall Street wag thinks Pfizer may remain intact

Pharmalot By Ed Silverman

Sanders, other lawmakers urge FDA approval of generic Crestor

Pharmalot By Ed Silverman

AstraZeneca sues FDA to prevent generic versions of Crestor